An AI pipelinethat screens the world for market-moving events while you sleep.
We scan global feeds around the clock, score every event by severity, and turn the ones that name an asset into a standing AI Analyst read — fundamentals, technicals, and a verdict. Every read states what would invalidate it.
This is the product, mid-run. Nothing here is staged.
The freshest AI Analyst read a second model just double-checked. The briefing that went out. The events it's tracking — each carrying its full history, not just today's headline. And the last alert it fired. Refreshed every 15 minutes. Real data, no edits.
The previous read, generated 3 days ago, was non-directional; it has turned bearish because diplomatic warming has shifted the near-term sector narrative from strategic scarcity toward less fragmented supply. The BRICS agenda also explicitly raises cooperation around logistics, energy storage and critical minerals, although its announced initiatives do not yet establish a binding rare-earth supply arrangement. That distinction keeps the sector-theme evidence less than definitive. The chart now supplies the confirmation that was missing: price is below declining medium- and long-term averages, weekly structure is lower, and negative momentum has been joined by above-normal participation on the latest decline. Price is pressing the 70.42 support shelf, but weak trend strength means a break could remain choppy rather than become an immediate sustained slide. The bearish evidence aligns across the sector theme and the chart. The recent decline indicates some scarcity-premium repricing is already underway, while the durable defense and domestic-production case remains a meaningful counterweight over a longer horizon.
- Diplomatic warming toward U.S.-China trade normalization likely reduces the strategic-scarcity premium supporting Western rare-earth producers.
- Price is below declining daily and weekly trend measures, with negative momentum and above-normal participation in the latest decline.
- Defense demand and prospective domestic production could preserve part of the strategic premium despite a near-term thaw.
- Weak trend strength and RSI near oversold leave scope for a choppy rebound even if the broader downside bias persists.
- The reference price is from 1 day ago — the market has been closed since, and the next open can gap well away from it before the picture updates
Energy stress cools from Friday’s spike but remains entrenched. Brent at 104.6 and WTI at 100.1 give back ~4% intraday yet sit on hefty 30‑day gains (+18–20%), while equities stay composed (SPX 7657, NDX 29368) and volatility eases (VIX 15.8). Rates stay firm into a Fed-heavy week (US10Y 4.97%, MOVE 82) and the dollar is inert (DXY 99.1), signaling the crude premium is partly priced but unresolved.
SEV 8Red Sea–Suez transit normalization
Reports of renewed Saudi–Houthi clashes near Bab al‑Mandeb, a Saudi pipeline shutdown and local diesel shortages arrive as Brent retreats to 104.6 from a 110.2 high and heating oil snaps lower to 4.77. The persistence test still leans sticky: Houthis seized Mocha and pushed toward the Hanish/Perim approaches, Saudi Yanbu flows to Asia already diverted, and transits through Bab al‑Mandeb are down 60–70% with Saudi Red Sea flows collapsing to ~400 kb/d by August, per cited trackers. Workarounds keep barrels moving but lengthen voyages, tighten VLCC supply and lift war‑risk premia—supporting crude above $100 and freight proxies (FRO 49.2 at highs, ZIM 29.6 strong); a credible naval corridor or reinstated war‑risk cover would unwind a chunk fast, while a full chokepoint shutdown risks another leg higher toward prior $115–$120 stress marks reported by Reuters.
SEV 5ivonescimab–Keytruda NSCLC survival challenge
Akeso/Summit reported a preplanned overall‑survival win for ivonescimab over Merck’s Keytruda in first‑line PD‑L1‑positive NSCLC, with FiercePharma flagging ~27% lower death risk and stronger PD‑L1‑high signals. MRK trades softer (143.9, intraday ‑1.1%, 5d ‑5.5%), suggesting partial pricing ahead of full data at WCLC (Sept 12–15); durable, globally replicable OS would threaten Keytruda’s franchise, while China‑only evidence and mixed Western read‑throughs argue for a two‑step rerating pending HARMONi global trials.
What changed: Al Jazeera and AP report renewed, heavy exchanges between Saudi forces and Houthi units around the Bab al‑Mandeb and a fresh Houthi coastal advance south along Yemen’s Red Sea coast; reporters also cite a…
- AIS shows commercial transits through Bab al‑Mandeb return to pre‑attack levels (horizon: 24h)
- major reinsurer/war‑risk underwriter restores corridor coverage notices (horizon: 48h)
- report of multi‑week shutdown at Jizan or a southern export/load terminal (horizon: 48h)
What changed: Akeso and Summit reported a preplanned Phase‑3 HARMONi‑2 overall‑survival (OS) win for ivonescimab versus Merck’s Keytruda in first‑line, PD‑L1‑positive non‑small‑cell lung cancer — FiercePharma cites a…
- full HARMONi‑2 OS numerical data presented at WCLC (horizon: 48h)
- detailed subgroup / PD‑L1‑high hazard ratios released (horizon: 48h)
- global HARMONi trial (HARMONi‑3 / HARMONi‑7) interim/final readouts or updates (horizon: 1m)
Multi-% Brent spike as strikes on multiple East-West pumping stations threaten 3-4M bpd of Saudi crude export capacity
Moderate BTC risk-off, because a second Trezor-linked email breach enables scaled phishing of hundreds of thousands of crypto holders, not the wallet itself.
Multi-% intraday Brent spike to 7-month high, because new wave of Hormuz shipping attacks and tanker sinkings shrinks transits further
Destruction of five Iranian tankers plus IRGC warning to Gulf tankers tightens already-crippled Hormuz crude flows; multi-% Brent risk
Multi-% intraday move in crude and risk assets, as US destroys five Iranian tankers and Iran fires ballistic missiles at a Jordanian base in a fresh escalation step.
The bigger the moment, the faster you hear.
One desk, always on. Five speeds of contact — so urgency decides when you're interrupted, not a schedule.
Always watching
50+ global feeds scanned around the clock. Nothing waits for a batch window.
The moment it breaks
A high-severity event triggers a flash alert within minutes — email and push, straight to your phone — and the AI Analyst prepares a read on the affected assets immediately. Rare by design: only when it's big.
The standing read
AI Analyst reads refresh around the clock as news and price actually change — the dashboard never shows a stale verdict.
As it develops
Notable events roll up every hour, so you track a story without watching the wire.
The full picture
Everything synthesized into one coherent briefing, delivered just before the stock market opens — synthesis, context, and what to watch next.
How a headline becomes an asset read and your morning briefing.
Around the clock, the pipeline reads 50+ global feeds and filters hundreds of headlines down to the ones that matter. Models do the judging — severity, direction, conviction — and deterministic code enforces the discipline: repeats can't re-alert, a verdict into a binary event is withheld, and an unconvinced model is allowed to say “no read.” Where model and rulebook disagree, the rulebook wins.
Ingest
50+ global sources scanned continuously, around the clock.
Triage
Every headline scored 0–10 on what's new today — repeats and echoes are suppressed, not re-alerted. The biggest fire a flash alert within minutes.
Cluster
Related headlines merge into long-lived events, each keeping a timeline of beats — the anchor developments that show how the situation develops, not just where it stands.
Analyze
Each event gets a full written analysis: what happened, why it matters for markets, which assets it touches, and concrete things to watch with horizons — grounded in a live market snapshot and the event's own history.
Verdict
Every asset an event names gets an analyst-style read — fundamentals, technicals, and a weighed verdict — grounded in the event's context and refreshed when the news or the chart actually changes.
Digest
Once a day, just before the stock market opens: a coherent briefing — synthesis across every live event, and what to watch.
Outcomes you can feel, mechanisms you can trust.
Three things you walk away with, and three things that make them possible.
A standing read on every asset in the news
When an event names an asset, the AI Analyst writes a full read — fundamentals, technicals, and a weighed verdict — and keeps it fresh around the clock as news and price change.
Never miss the moment
A high-severity event triggers a flash alert by email and push within minutes — with the AI Analyst's read on the affected assets right behind it. Quiet days stay quiet.
Stay informed in 2 minutes
One coherent briefing a day, delivered just before the stock market opens. The context a friend in finance would text you — on the dashboard & straight to your inbox.
Events live, not headlines
Stories cluster across sources and survive for days, each carrying its timeline of beats and anchor developments — how the situation develops, not just today's snapshot. New headlines update the picture; they don't restart the alarm, and a repeat doesn't even regenerate the read.
Two models, one verdict
One frontier model does the analysis; an independent second one checks it. Disagreement is shown on the read, not hidden.
AI in the open
A multi-stage pipeline triages hundreds of headlines every day, clusters them into events, analyzes scenarios, and writes your briefing. We show the work — sources, confidence, and what we don't know.
What we don't do.
There's a market full of services that will tell you what to buy. This isn't one of them — by design.
We don't tell you what to buy.
No "buy signals". No "strong sells". You make the call — we just make sure you're not surprised by what's moving the world.
We don't sell predictions.
We sell probabilities with expiry dates. Every scenario tells you what would prove it wrong, and when the analysis goes stale.
We don't write opinion.
No analyst pretending to know. The pipeline reads the news, scores it, tracks it, and explains it. The bias of a guru, removed.
Things people ask before signing up.
Is this financial advice?
What is an AI Analyst read?
What sources does it read?
How is this different from a Bloomberg terminal or a Substack?
What if the AI is wrong?
Can AI really call a black swan?
Can I customize what I get?
How often will I hear from you?
What does it cost?
See what the world is doing now, as it develops.
Create an account to start your free trial.